What this index holds, how it is built, and what its record does not cover. Morningstar Indexes, built with PitchBook.
The Morningstar PitchBook Global BioPharma Unicorn Index tracks the largest privately held, venture capital-backed companies in the BioPharma industry vertical with valuations of at least $1 billion. BioPharma companies exploit cellular and biomolecular processes to develop innovative therapeutics and technologies.
One industry vertical, biopharma, rather than the whole market.
Run by Morningstar Indexes, built with PitchBook. PrePost has no relationship with the provider and is not paid to list this index.
The index began on 2023-10-25. Its performance record starts 2021-03-22, so the years before 2023-10-25 are backfilled rather than live. A long-run return quoted for this index is mostly a backtest.
The provider's own reporting notes that where transactions are infrequent, secondary-market marks can stay unchanged even as new information emerges.
| Field | Value |
|---|---|
| Provider | Morningstar Indexes, built with PitchBook |
| Inception | October 25, 2023 |
| Performance record starts | March 22, 2021 |
| Constituents | 24 |
| Weighting | Market Capitalization |
| Rebalance | Quarterly (next September 21, 2026) |
| Reconstitution | Semi Annually |
| Currency | USD |
| How constituents are priced | Not published as a rule. The provider's quarterly reporting on this family sources its secondary-market marks to Caplight, alongside Morningstar and PitchBook data. |
| Published methodology | None that PrePost could find on the provider's own pages. |
| Variants | Morningstar PitchBook Global BioPharma Unicorn PR USD Morningstar PitchBook Global BioPharma Unicorn GR USD |
| Identifiers | FS0000IE7R (Morningstar fund ID) |
Named constituents as of August 31, 2026.
Membership as the index provider published it on this date. PrePost shows which companies are in the index, not their weights.
| Company | PrePost | Estimate | Confidence |
|---|---|---|---|
| Biosplice Therapeutics | Named | No PrePost page | |
| Altos Labs | Named | No PrePost page | |
| AbogenBio | Named | No PrePost page | |
| Xaira Therapeutics | Named | No PrePost page | |
| insitro | Named | No PrePost page | |
| ArsenalBio | Named | No PrePost page | |
| Pathos | Named | No PrePost page | |
| Sironax | Named | No PrePost page | |
| Isomorphic Labs | Named | No PrePost page | |
| Trialspark | Named | No PrePost page | |
| NewLimit | Named | No PrePost page | |
| Valo | Named | No PrePost page | |
| RefleXion | Named | No PrePost page | |
| Belief BioMed | Named | No PrePost page | |
| Shanghai Cell Therapy Group | Named | No PrePost page | |
| Mammoth Biosciences | Named | No PrePost page | |
| Pharmaron Ningbo | Named | No PrePost page | |
| Orca Bio | Named | No PrePost page | |
| Treeline Biosciences | Named | No PrePost page | |
| Kallyope | Named | No PrePost page | |
| Adimab | Named | No PrePost page | |
| Enveda Biosciences | Named | No PrePost page | |
| TrueBinding | Named | No PrePost page | |
| Accutar Biotech | Named | No PrePost page | |
Verified means a full PrePost profile with sourced figures. Listed means the company is named here because a benchmark we track names it; PrePost has published no figure for it and does not rank it. Public means it has left the private market and can be bought through any broker.
None that PrePost tracks. That does not mean none exists: a product can track an index without PrePost having verified it, and PrePost lists a vehicle only once it can source what the vehicle is and what it holds.
Claim or correct this listing →
Tell us what is wrong, or send the methodology we could not find, and we will correct the page and date the change. PrePost takes no payment for a listing, and confirming details is not an endorsement in either direction.
An index is not an investment, and a product that tracks one may not hold what it holds. This page describes the index, not any product. Not investment advice.
Last updated 2026-09-20. See also how we verify and our disclaimer.